Member database | CDD |
CDD type | domain |
Short name | RHD-n_NFkB1 |
Set | RHD-n |
Description
References
1.Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy. Qin ZH, Tao LY, Chen X. Acta Pharmacol Sin 28, 1859-72, (2007). PMID: 18031598
2.Nuclear factor-kappaB activation: from bench to bedside. Sethi G, Sung B, Aggarwal BB. Exp Biol Med (Maywood) 233, 21-31, (2008). PMID: 18156302
3.Focus on molecules: nuclear factor-kappaB. Srivastava SK, Ramana KV. Exp Eye Res 88, 2-3, (2009). PMID: 18472097
4.Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis. Visekruna A, Joeris T, Seidel D, Kroesen A, Loddenkemper C, Zeitz M, Kaufmann SH, Schmidt-Ullrich R, Steinhoff U. J Clin Invest 116, 3195-203, (2006). PMID: 17124531
5.Peripheral blood mononuclear cell NF-kappaB p105 mRNA decreases during asthmatic attacks. Matsumura Y. Biomed Pharmacother 62, 147-52, (2008). PMID: 17913447
6.Role of nuclear factor kappaB in the central nervous system. Malek R, Borowicz KK, Jargiello M, Czuczwar SJ. Pharmacol Rep 59, 25-33, (2007). PMID: 17377203
7.NF-kappa B: a new player in angiostatic therapy. Tabruyn SP, Griffioen AW. Angiogenesis 11, 101-6, (2008). PMID: 18283548
8.Structure of the NF-kappa B p50 homodimer bound to DNA. Muller CW, Rey FA, Sodeoka M, Verdine GL, Harrison SC. Nature 373, 311-7, (1995). View articlePMID: 7830764
9.NF-kappa B-mediated adaptive resistance to ionizing radiation. Ahmed KM, Li JJ. Free Radic Biol Med 44, 1-13, (2008). PMID: 17967430
10.Crosstalk via the NF-kappaB signaling system. Basak S, Hoffmann A. Cytokine Growth Factor Rev 19, 187-97, (2008). PMID: 18515173
11.Proteolysis of NF-kappaB1 p105 is essential for T cell antigen receptor-induced proliferation. Sriskantharajah S, Belich MP, Papoutsopoulou S, Janzen J, Tybulewicz V, Seddon B, Ley SC. Nat Immunol 10, 38-47, (2009). PMID: 19060899
12.NF-kappa B, KBF1, dorsal, and related matters. Gilmore TD. Cell 62, 841-3, (1990). View articlePMID: 2203533
13.NF-kappaB and the regulation of hematopoiesis. Bottero V, Withoff S, Verma IM. Cell Death Differ 13, 785-97, (2006). PMID: 16528384
14.Linkage of Crohn's disease-related serological phenotypes: NFKB1 haplotypes are associated with anti-CBir1 and ASCA, and show reduced NF-kappaB activation. Takedatsu H, Taylor KD, Mei L, McGovern DP, Landers CJ, Gonsky R, Cong Y, Vasiliauskas EA, Ippoliti A, Elson CO, Rotter JI, Targan SR. Gut 58, 60-7, (2009). PMID: 18832525
15.NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases. Mourkioti F, Rosenthal N. J Mol Med (Berl) 86, 747-59, (2008). PMID: 18246321
16.Regulation and function of NF-kappaB transcription factors in the immune system. Vallabhapurapu S, Karin M. Annu. Rev. Immunol. 27, 693-733, (2009). View articlePMID: 19302050
17.NF-kappa B1 p105 regulates T cell homeostasis and prevents chronic inflammation. Chang M, Lee AJ, Fitzpatrick L, Zhang M, Sun SC. J Immunol 182, 3131-8, (2009). PMID: 19234210
18.Signaling to NF-kappaB. Hayden MS, Ghosh S. Genes Dev. 18, 2195-224, (2004). View articlePMID: 15371334
19.NF-kappaB as a potential molecular target for cancer therapy. Lee CH, Jeon YT, Kim SH, Song YS. Biofactors 29, 19-35, (2007). PMID: 17611291
20.Multiple redox regulation in NF-kappaB transcription factor activation. Piette J, Piret B, Bonizzi G, Schoonbroodt S, Merville MP, Legrand-Poels S, Bours V. Biol. Chem. 378, 1237-45, (1997). PMID: 9426183
21.Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Beinke S, Ley SC. Biochem J 382, 393-409, (2004). PMID: 15214841
22.The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Grimm S, Baeuerle PA. Biochem J 290 ( Pt 2), 297-308, (1993). PMID: 8452515
23.Platelet-activating factor induces the processing of nuclear factor-kappaB p105 into p50, which mediates acute bowel injury in mice. Liu SX, Tian R, Baskind H, Hsueh W, De Plaen IG. Am J Physiol Gastrointest Liver Physiol 297, G76-81, (2009). PMID: 19460845
24.Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B lymphocytes. Moran ST, Cariappa A, Liu H, Muir B, Sgroi D, Boboila C, Pillai S. J Immunol 179, 195-200, (2007). PMID: 17579038
25.Nuclear factor-kappaB1: regulation and function. Pereira SG, Oakley F. Int J Biochem Cell Biol 40, 1425-30, (2008). PMID: 17693123
26.Shared principles in NF-kappaB signaling. Hayden MS, Ghosh S. Cell 132, 344-62, (2008). PMID: 18267068
28.NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M. Nature 453, 807-11, (2008). PMID: 18432192
29.Estrogen, NFkappaB, and the heat shock response. Stice JP, Knowlton AA. Mol Med 14, 517-27, (2008). PMID: 18431462
30.Rel/NF-kappa B transcription factors and I kappa B inhibitors: evolution from a unique common ancestor. Huguet C, Crepieux P, Laudet V. Oncogene 15, 2965-74, (1997). PMID: 9416840
31.NF-kappaB and cancer-identifying targets and mechanisms. Naugler WE, Karin M. Curr Opin Genet Dev 18, 19-26, (2008). PMID: 18440219
32.NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Lenardo MJ, Baltimore D. Cell 58, 227-9, (1989). PMID: 2665943
33.Nuclear factor-kappaB in development, prevention, and therapy of cancer. Van Waes C. Clin Cancer Res 13, 1076-82, (2007). PMID: 17317814
34.The inhibitory ankyrin and activator Rel proteins. Nolan GP, Baltimore D. Curr Opin Genet Dev 2, 211-20, (1992). PMID: 1386268
35.The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer. Al-Saad S, Al-Shibli K, Donnem T, Persson M, Bremnes RM, Busund LT. Br J Cancer 99, 1476-83, (2008). PMID: 18854838
36.Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation. Minami M, Shimizu K, Okamoto Y, Folco E, Ilasaca ML, Feinberg MW, Aikawa M, Libby P. J Biol Chem 283, 9692-703, (2008). PMID: 18270204
37.Nuclear factor-kappaB, an unappreciated tumor suppressor. Chen F, Castranova V. Cancer Res 67, 11093-8, (2007). PMID: 18056430
38.The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target. Yates LL, Gorecki DC. Acta Biochim Pol 53, 651-62, (2006). PMID: 17068636
39.Beyond IkappaBs: alternative regulation of NF-kappaB activity. Neumann M, Naumann M. FASEB J. 21, 2642-54, (2007). PMID: 17431096
40.Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages. Loniewski KJ, Patial S, Parameswaran N. Mol. Immunol. 44, 3715-23, (2007). View articlePMID: 17507094
41.NF-kappa B: a lesson in family values. Thanos D, Maniatis T. Cell 80, 529-32, (1995). PMID: 7867060